Novartis tips complex manufacturing to insulate Sandostatin from generics
Novartis expects generics to slowly erode sales of Sandostatin given production challenges.
Archives for February 3, 2020
Pfizer's CDMO unit drives growth at hospital business
Pfizer attributes performance of contract manufacturing unit as driver of growth at hospital business.
US FDA finds fault with standards at Aurobindo's oral solids facility
Aurobindo Pharma reveals US FDA found objectionable conditions at its oral solids manufacturing facility.
PPD prices IPO, seeking $1.5bn at a $9bn valuation
CRO PPD sets terms of planned IPO, outlining plans to raise $1.5bn at a valuation north of $9bn.